Xencor (XNCR)
(Delayed Data from NSDQ)
$19.98 USD
+0.75 (3.90%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $19.98 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Brokerage Reports
0 items in cart
Xencor, Inc. [XNCR]
Reports for Purchase
Showing records 161 - 180 ( 216 total )
Company: Xencor, Inc.
Industry: Medical - Drugs
3Q Financials; Programs on Track for Key Readouts Ahead, Reiterate OUTPERFORM and $27 PT
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
First Patient Dosed in XNCR''s Ph 1 Study of Bispecific XmAb14045
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
2Q Results, Well Capitalized with Multiple Data Catalysts over Next Year, Reiterate OP
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences: Upcoming Events for the Week of August 1
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
Analyst Day: Novartis Bispecifics Partnership, Productive Platform, Reiterate OP
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
Final Ph 1 Data Highlights Differentiated Therapeutic Profile of ''7195 in Asthma, Reiterate OP
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
Q1 EPS; On Track for Multiple Trial Initiations in 2016; Key Readouts Ahead
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Biotechnology AACR Roundup for Covered Companies.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
4Q EPS; With Multiple Programs Entering Clinic in 2016, Breadth of XNCR''s Pipeline Opportunity Remains Underappreciated, Reiterate OP
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of March 7
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of Feb. 1This report contains brief updates on the following: SRPT, RGLS, BMRN, CBYL, CLDX, EPRS, LXRX, PCRX, PRTA, PTCT, RPTP, TTPH, RARE, VTAE, ICPT, CERU, FCSC, GBT, TSRO, TRVN, IRWD, MRTX, DNAI, XNCR. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
XNCR 3Q Results, We Expect Next 12 months to be Transformational as Multiple XmAb Programs Advance
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of Nov. 2This report contains brief updates on the following: DYAX, ANAC, IRWD, ECYT, FATE, XNCR, RGLS, MGNX, FCSC, SNSS, INFI, MDVN, RPTP, SRPT, XOMA, AGTC, EPZM, BLUE, PTCT, CATB, EPRS, ABUS, ICPT. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
How Will the Rubble Bounce, or Ideas on the Recent Sell-Off
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
How Will the Rubble Bounce, or Ideas on the Recent Sell-Off
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
AMGN and XNCR to Collaborate on Six Preclinical Bispecific Programs from XNCR
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Xencor, Inc.
Industry: Medical - Drugs
Company: Xencor, Inc.
Industry: Medical - Drugs
Biotechnology/Biopharmaceuticals - Next Generation Antibody Therapeutics
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D